Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.

Case–control study Cáncer de pulmón de células pequeñas Estudio de casos y controles Indoor radon Radón en interiores Small cell lung cancer Tabaco Tobacco

Journal

Archivos de bronconeumologia
ISSN: 2173-5751
Titre abrégé: Arch Bronconeumol (Engl Ed)
Pays: Spain
ID NLM: 101777538

Informations de publication

Date de publication:
13 Feb 2021
Historique:
received: 03 12 2020
revised: 06 01 2021
accepted: 26 01 2021
entrez: 21 3 2021
pubmed: 22 3 2021
medline: 22 3 2021
Statut: aheadofprint

Résumé

Residential radon is considered the second cause of lung cancer and the first in never smokers. Nevertheless, there is little information regarding the association between elevated radon levels and small cell lung cancer (SCLC). We aimed to assess the effect of residential radon exposure on the risk of SCLC in general population through a multicentric case-control study. A multicentric hospital-based case-control study was designed including 9 hospitals from Spain and Portugal, mostly including radon-prone areas. Indoor radon was measured using Solid State Nuclear Track Detectors at the Galician Radon Laboratory. A total of 375 cases and 902 controls were included, with 24.5% of cases being women. The median number of years living in the measured dwelling was higher than 25 years for both cases and controls. There was a statistically significant association for those exposed to concentrations higher than the EPA action level of 148Bq/m Radon exposure seems to increase the risk of small cell lung cancer with a linear dose-response pattern. Tobacco consumption may also produce an important effect modification for radon exposure.

Identifiants

pubmed: 33744027
pii: S0300-2896(21)00052-1
doi: 10.1016/j.arbres.2021.01.027
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Ángeles Rodríguez-Martínez (Á)

Service of Medical Oncology, University Hospital Complex of Pontevedra, Spain; Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain.

Alberto Ruano-Ravina (A)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública, CIBERESP), Spain; Instituto de Investigaciones Sanitarias de Santiago de Compostela (IDIS), Spain. Electronic address: alberto.ruano@usc.es.

María Torres-Durán (M)

Service of Neumology, University Hospital Complex of Vigo, Spain.

Mariano Provencio (M)

Service of Medical Oncology, Puerta del Hierro University Hospital of Madrid, Spain.

Isaura Parente-Lamelas (I)

Service of Neumology, University Hospital Complex of Ourense, Spain.

Iria Vidal-García (I)

Service of Neumology, University Hospital Complex of A Coruña, Spain.

Cristina Martínez (C)

National Institute of Silicosis, University Hospital of Asturias, Oviedo, Spain.

Jesús Hernández-Hernández (J)

Service of Neumology, University Hospital of Ávila, Spain.

Ihab Abdulkader-Nallib (I)

Service of Pathological Anatomy, University Complex of Santiago de Compostela, Spain.

Olalla Castro-Añón (O)

Service of Neumology, Universitary Hospital Complex of Lugo, Spain.

Leonor Varela-Lema (L)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública, CIBERESP), Spain; Instituto de Investigaciones Sanitarias de Santiago de Compostela (IDIS), Spain.

María Piñeiro-Lamas (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública, CIBERESP), Spain.

Paula Sales Fidalgo (PS)

Centro Hospitalar do Porto, Oncology Service, Porto, Portugal.

Alberto Fernández-Villar (A)

Service of Neumology, University Hospital Complex of Vigo, Spain.

Juan Barros-Dios (J)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública, CIBERESP), Spain; Service of Preventive Medicine, University Complex of Santiago de Compostela, Spain.

Mónica Pérez-Ríos (M)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública, CIBERESP), Spain; Instituto de Investigaciones Sanitarias de Santiago de Compostela (IDIS), Spain.

Classifications MeSH